3STRICKER BH, De JONG PA, SCHREUDER, et al. Loss of taste sensation in terbinafine administration [ J ]. Ned Tijdschr Geneeskd, 1992, 136 (49) :2438 - 2440.
4STRICKER BH, van RIEMSDI JK MM, STURKENBOOM MC, et al. Taste loss to terbinafine : a case - control study of potential risk factors [J].Br J Clin Pharmacol,1996,42(3) :313 -318.
5Gupta AK, Shear NH. Safety review of the oral antifungal agents used to treat superficial mycoses [ J ]. Int J Dermatol, 1999, 38(Suppl 2) :40-52.
6Hall M, Monka C, Krupp P, et al. Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients [ J]. Arch Dermatol, 1997, 33 : 1213- 1219.
7Stricker BH, Van Riemsdijk MM, Sturkenboom MC, et al. Tasty loss to terbinafine: a case-control study of potential risk factors[ J]. Br J Clin Pharmacol, 1996, 42: 313-318.
8Hall M, Krupp P, Monka C, et al. Safety of oral terbinafine: results of a postmarketing surveillance study in 25 884 patients[J]. Arch Dermotol, 1997, 33(10) : 1213- 1219.
9Bong JL, Lucke TW, Evans CD. Persistent impairment of taste resulting from terbinafine[ J]. B J Dermatol, 1998, 139(4) :747-748.
10Stricker BH, Van Riemsdijk MM, Sturkenboom MC, et al. Taste loss to terbinafine: a case-control study of potential risk factors[J]. Br J Clin Pharmacol, 1996, 42 (3) : 313-318.
